VU 0357121 化学構造
分子量: 305.32


Quality Control & MSDS


  • Compare GluR Inhibitors
  • 研究分野



情報 VU 0357121は、33nMのEC50によるmGlu5レセプターの新しいアロステリックモジュレーターです。
目標 mGlu5
IC50 33 nM [1]
In vitro試験 VU0357121 do not bind at the MPEP allosteric site of mGlu5, thus do not possess mGlu5 NAM activity. The A809V/rmGlu5 mutation inhibited the ability of VU0357121 to shift the glutamate concentration−response curve, whereas the response to VU0357121 is not altered by the F585I/rmGlu5 mutation. [1] VU0357121 show weaker cooperativity in the Ca2+ mobilization assay in the low-expressing HEK293A-mGlu5 cell line. [2]
In vivo試験

推薦された実験操作 (公開の文献だけ)

キナーゼアッセイ: [1]

Radioligand Binding Assay The allosteric antagonist MPEP analogue [3H]methoxyPEPy is used to evaluate the ability of test compounds to interact with the MPEP site on mGlu5. Membranes are prepared from rat mGlu5 HEK293 cells. VU0357121 is diluted in assay buffer (50 mM Tris/0.9% NaCl, pH 7.4) to a 5× stock, and 100 μL of the test compound is added to each well of a 96 deep-well assay plate. Three hundred microliter aliquots of membranes diluted in assay buffer (20 μg/well) are added to each well. One hundred microliters of [3H]methoxyPEPy (2 nM final concentration) is added, and the reaction is incubated at room temperature for 1 h with shaking. After the incubation period, the membrane-bound ligand is separated from free ligand by filtration through glass-fiber 96-well filter plates. The contents of each well are transferred simultaneously to the filter plate and washed 3−4 times with assay buffer using a cell harvester. Forty microliters of scintillation fluid is added to each well and the membrane-bound radioactivity determine by scintillation counting. Nonspecific binding is estimated using 5 μM MPEP. Concentration−response curves are generated using a four parameter logistical equation in GraphPad Prism.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesBaboonDogMonkeyRabbitGuinea pigRatHamsterMouse
Weight (kg)121031.
Body Surface Area (m2)
Km factor202012128653
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)



Download VU 0357121 SDF
分子量 305.32


CAS No. 433967-28-3
保管 2年-20℃
6月-80℃in DMSO
溶解度 (25°C) * In vitro DMSO 61 mg/mL (199.79 mM)
<1 mg/mL (<1 mM)
エタノール 21 mg/mL (68.78 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
化学名 4-butoxy-N-(2,4-difluorophenyl)benzamide




電話番号: +1-832-582-8158 Ext:3月曜日〜金曜日 9:00 AM–5:00 PM (米国中部標準時)


* 必須

Related GluR 阻害剤

  • FLI-06

    FLI-06 is a novel inhibitor of Notch signaling with EC50 of 2.3 μM.

  • Rotigotine

    Rotigotine is a dopamine receptor agonist, used in the treatment of Parkinson's disease and restless legs syndrome.

  • Meclofenamate Sodium

    Meclofenamate Sodium is a dual COX-1/COX-2 inhibitor with IC50 of 40 nM and 50 nM, respectively, used in the treatment of joint, muscular pain, arthritis and dysmenorrhea.

  • MK-801 (Dizocilpine)

    MK-801 (Dizocilpine) is a potent N-methyl-D-aspartate (NMDA) receptor antagonist with Ki of 30.5 nM.

  • Latrepirdine

    Latrepirdine is an antihistamine drug.

  • (-)-Huperzine A (HupA)

    (-)-Huperzine A (HupA)は アセチルコリンエステラーゼ(AChE)の強力で、非常に特定で、可逆的な阻害剤で、Ki が 7 nMです。

    Features:与Tacrine, Donepezil, 和 Rivastigmine相比,(-)-Huperzine A具有 更好的穿透血脑屏障能力,更高的口服生物有效性,及持续时间更长的乙酰胆碱酯酶抑制能力。

  • Ifenprodil Tartrate

    Ifenprodil Tartrate is an atypical noncompetitive antagonist at the NMDA receptor, it interacts with high affinity at a homogeneous population of NMDA receptors in neonatal rat forebrain with IC50 of 0.3 μM.

  • NMDA (N-Methyl-D-aspartic acid)

    NMDA(N-Methyl-D-aspartic acid)は、NMDA受容体 のための特定の作用薬で、 L-グルタミン酸塩受容体の動作を模倣すること。

  • LY404039

    LY404039は、組み換え型人間の mGlu2、 mGlu3の強力な作用薬でKi がそれぞれ 149 nM、92 nM、88 nMです。


  • ADX-47273

    ADX-47273は、強力で特定のmGlu5受容体拮抗剤で、IC50 が 0.17μMです。


Tags: VU 0357121を買う | VU 0357121供給者 | VU 0357121を購入する | VU 0357121費用 | VU 0357121生産者 | オーダーVU 0357121 | VU 0357121代理店